← Browse by Condition
Medical Condition

t lgl leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06530550 Phase 2
Recruiting

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Enrollment
51 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
View Trial →